Abstract: According to one embodiment, a semiconductor device includes an insulating substrate, an oxide semiconductor layer, a gate insulating film, a gate electrode, a first insulating film and a second insulating film. The oxide semiconductor layer is provided on the insulating substrate and includes first and second low-resistance regions and a high-resistance region between the first and second low-resistance regions. The gate insulating film is provided on the high-resistance region of the oxide semiconductor layer. The gate electrode is provided on the gate insulating film. The first insulating film is provided above the gate electrode, gate insulating film and first and second low-resistance regions of the oxide semiconductor layer, and contains at least fluorine. The second insulating film is provided on the first insulating film, and contains aluminum.

Abstract: The present invention provides a heterocyclic compound having a HDAC inhibitory action, and useful for the treatment of central nervous system diseases including neurodegenerative disease, and the like, and a medicament comprising the compound. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.

Abstract: A light exposure system includes an external apparatus that is placed on a facility and a portable terminal that communicates with the external apparatus, and manages the amount of light which the user is exposed to. Furthermore, the external apparatus transmits information regarding the amount of light which the user is exposed to, to the portable terminal. In addition, the portable terminal includes: a terminal-side controller which receives the information from the external apparatus and calculates the cumulative value of the amount of light from the information, when a communication is established with the external apparatus; and a display that displays the cumulative value calculated by the terminal-side controller.

Abstract: The problem of the present invention is to provide a compound having a superior ROR?t inhibitory action, and useful as a prophylactic or therapeutic agent for psoriasis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, rheumatoid arthritis, multiple sclerosis, uveitis, asthma, ankylopoietic spondylarthritis, systemic lupus erythematosus, chronic obstructive pulmonary disease or the like. The present invention relates to a compound represented by the formula (I): [wherein each symbol is as described in the DESCRIPTION] or a salt thereof, which has an ROR?t inhibitory action, and useful as a prophylactic or therapeutic agent for psoriasis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, rheumatoid arthritis, multiple sclerosis, uveitis, asthma, ankylopoietic spondylarthritis, systemic lupus erythematosus, chronic obstructive pulmonary disease or the like.

Abstract: A light-irradiating apparatus which emits light for activating a body is provided. The light-irradiating apparatus includes a blue light source, a white light source, and a controller. The controller controls the white light source and the blue light source, and adjusts irradiation intensities of light emitted by the blue light source and the white light source. The controller causes the white light source to continuously maintain an on state and causes the blue light source to repeat an on state and an off state. The controller causes a sum of the irradiation intensity of the light which is emitted by the white light source and the irradiation intensity of the light which is emitted by the blue light source to be greater than or equal to a biological effect threshold at which light produces an effect of activating the body.

Abstract: A light exposure system includes an external apparatus that is placed on a facility and a portable terminal that communicates with the external apparatus, and manages the amount of light which the user is exposed to. Furthermore, the external apparatus transmits information regarding the amount of light which the user is exposed to, to the portable terminal. In addition, the portable terminal includes: a terminal-side controller which receives the information from the external apparatus and calculates the cumulative value of the amount of light from the information, when a communication is established with the external apparatus; and a display that displays the cumulative value calculated by the terminal-side controller.

Abstract: A light emission apparatus emits light that activates a human body. The light emission apparatus includes a light-emitting module that emits light from a light emission region. The light emission region includes a first light emission region that emits light having a first luminance and a second light emission region that emits light having a second luminance greater than the first luminance. The second light emission region is a different region than the first light emission region. The first light emission region is located in a central region of the light emission region. The second light emission region is peripheral to the first light emission region. The light having the first luminance emitted from the first light emission region has a predetermined wavelength that activates the human body.

Abstract: The present invention provides a heterocyclic compound having an ROR?t inhibitory action. The present invention relates to a compound represented by the formula (I): wherein Ar is a the partial structure (1) to the partial structure (5), Q is a bivalent group selected from the group consisting of (Ia)-(If), and B is a ring optionally having substituent(s), or a salt thereof.

Abstract: A display device of the present disclosure includes a plurality of pixels, in which a pixel includes a light-emitting element, a drive circuit which has a thin film transistor driving the light-emitting element, and a coupling unit which connects the light-emitting element and the drive circuit to each other, the light-emitting element has a configuration in which an organic layer including a light-emitting layer is interposed between a transparent electrode and a reflective electrode, the thin film transistor has a configuration which includes a semiconductor layer, an insulation layer, a first electrode layer, and a second electrode layer, and the coupling unit includes a metal layer which is thinner than the first electrode and the second electrode of the thin film transistor the metal layer being disposed in one portion of the coupling unit.

Abstract: According to one embodiment, a semiconductor device includes an insulating substrate, an oxide semiconductor layer, a gate insulating film, a gate electrode, a first insulating film and a second insulating film. The oxide semiconductor layer is provided on the insulating substrate and includes first and second low-resistance regions and a high-resistance region between the first and second low-resistance regions. The gate insulating film is provided on the high-resistance region of the oxide semiconductor layer. The gate electrode is provided on the gate insulating film. The first insulating film is provided above the gate electrode, gate insulating film and first and second low-resistance regions of the oxide semiconductor layer, and contains at least fluorine. The second insulating film is provided on the first insulating film, and contains aluminum.

Abstract: The problem of the present invention is to provide a compound having a superior ROR?t inhibitory action, and useful as a prophylactic or therapeutic agent for psoriasis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, rheumatoid arthritis, multiple sclerosis, uveitis, asthma, ankylopoietic spondylarthritis, systemic lupus erythematosus, chronic obstructive pulmonary disease or the like. The present invention relates to a compound represented by the formula (I): [wherein each symbol is as described in the DESCRIPTION] or a salt thereof, which has an ROR?t inhibitory action, and useful as a prophylactic or therapeutic agent for psoriasis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, rheumatoid arthritis, multiple sclerosis, uveitis, asthma, ankylopoietic spondylarthritis, systemic lupus erythematosus, chronic obstructive pulmonary disease or the like.

Abstract: The present invention relates to compound (I) or a salt thereof which has a ROR?t inhibitory action. In the formula (I), each symbol is as defined in the specification.

Abstract: Provided is a compound having a superior PKC inhibitory action, and useful as a prophylactic or therapeutic agent for immune diseases, inflammatory diseases and the like, or a salt thereof. A compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof has a superior PKC inhibitory action, and is useful as a prophylactic or therapeutic agent for immune diseases, inflammatory diseases and the like.

Abstract: The present invention provides a method for producing a silicon wafer including a step of, after growing the oxide film on one surface of a raw material silicon wafer by chemical-vapor deposition, performing double-side polishing of the raw material silicon wafer in such a manner that a suede polishing pad or a velour polishing pad with an asker-C rubber hardness of 50° or more but less than 90° is used for the oxide-film surface.

Abstract: The present invention provides a heterocyclic compound having an ROR?t inhibitory action. The present invention relates to a compound represented by the formula (I): wherein Ar is a the partial structure (1) to the partial structure (5), Q is a bivalent group selected from the group consisting of (Ia)-(If), and B is a ring optionally having substituent(s), or a salt thereof.

Abstract: Provided is a semiconductor device, including a transistor in which an oxide semiconductor film, a gate insulating film, and a gate electrode are stacked in order, in which the oxide semiconductor film includes a first region portion and a second region portion. The oxide semiconductor film includes indium (In), zinc (Zn), and one or more of tin (Sn), gallium (Ga), and aluminum (Al). The first region portion is located, in a thickwise direction, in vicinity of an interface between the oxide semiconductor film and the gate insulating film, in the oxide semiconductor film. A composition ratio of the one or more of tin, gallium, and aluminum in the first region portion is higher than a composition ratio of the one or more of tin, gallium, and aluminum in the second region portion.

Abstract: Provided is a semiconductor device that includes: a transistor; an oxide semiconductor film; a first conductive film electrically connected to the oxide semiconductor film; and a first insulating film provided between the first conductive film and the oxide semiconductor film.

Abstract: A heterocyclic compound having an ROR?t inhibitory activity, which is a compound of formula (I) or a salt thereof is provided. The compound has ring A, which is an optionally substituted cyclic group and is bound to a pyrazole ring though Q. Q is a bond, optionally substituted C1-10 alkylene, optionally substituted C2-10 alkenylene, or optionally substituted C2-10 alkynylene. R1 is a substituent. Ring B is a thiazole ring, an isothiazole ring or a dihydrothiazole ring, each of which is optionally further substituted by a substituent in addition to R2.

Abstract: Provided is a semiconductor device that includes a capacitor. The capacitor includes a hydrogen-containing film that is in contact with an oxide semiconductor film.

Abstract: A display device of the present disclosure includes a plurality of pixels, in which a pixel includes a light-emitting element, a drive circuit which has a thin film transistor driving the light-emitting element, and a coupling unit which connects the light-emitting element and the drive circuit to each other, the light-emitting element has a configuration in which an organic layer including a light-emitting layer is interposed between a transparent electrode and a reflective electrode, the thin film transistor has a configuration which includes a semiconductor layer, an insulation layer, a first electrode layer, and a second electrode layer, and the coupling unit includes a metal layer which is thinner than the first electrode and the second electrode of the thin film transistor the metal layer being disposed in one portion of the coupling unit.